Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review-Reference-Cited by-同舟云学术

Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review

Published:2020-10-17 Issue:18 Volume:80 Page:1929-1946
ISSN:0012-6667
Container-title:Drugs
language:en
Short-container-title:Drugs

Author:

Cantini Fabrizio^ORCID,Goletti Delia^ORCID,Petrone Linda^ORCID,Najafi Fard Saied,Niccoli Laura^ORCID,Foti Rosario^ORCID

Funder

Italian Ministry of Health

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40265-020-01421-w.pdf

Reference85 articles.

1. WHO. Coronavirus 2019. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—11-march-2020. Accessed 14 Mar 2020.

2. Ji W, Wang W, Zhao X, Zai J, Li X. Cross-species transmission of the newly identified coronavirus 2019-nCoV. J Med Virol. 2020;92:433–40.

3. Ziegler CGK, Allon SJ, Nyquist SK, Mbano IM, Miao VN, Tzouanas CN, et al. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell. 2020;181(5):1016–1035.e19. https://doi.org/10.1016/j.cell.2020.04.035.

4. Glowacka I, Bertram S, Müller MA, Allen P, Soilleux E, Pfefferle S, et al. Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. J Virol. 2011;85(9):4122–34. https://doi.org/10.1128/jvi.02232-10.

5. van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. 2020;382(16):1564–7. https://doi.org/10.1056/nejmc2004973.

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple antimicrobial and immune-modulating activities of cysteamine in infectious diseases;Biomedicine & Pharmacotherapy;2024-09

2. Enhanced Treatment in Severe-Critical COVID-19 With Tocilizumab, Remdesivir, Dexamethasone: A Jordanian Cohort Study;Cureus;2024-08-22

3. Identification of Potential Inhibitors of SARS-CoV-2 Using Machine Learning, Molecular Docking and MD Simulation;2024-08-20

4. Integrative analysis discovers Imidurea as dual multitargeted inhibitor of CD69, CD40, SHP2, lysozyme, GATA3, cCBL, and S-cysteinase from SARS-CoV-2 and M. tuberculosis;International Journal of Biological Macromolecules;2024-06

5. Identification of Potential Inhibitors of SARS-CoV-2 Using Machine Learning, Molecular Docking and MD Simulation;2024-05-02